RYZODEG INJ

Ryzodeg 10011J/ml Penfill 3 ml belongs to the class of medications called antidiabetics primarily used
for the treatment of both type 1 and type 2 diabetes mellitus. It maintains blood sugar levels in adults
and children. In Diabetes Mellitus Type I, the body does not produce enough insulin to regulate blood
sugar levels. On the other hand, in Diabetes Mellitus type 2, either the body stops producing enough
insulin (a hormone that helps lower blood sugar levels), or there is resistance to insulin action. As a
result, insulin is produced in large quantities, but it is not capable of operating on the body’s organs.

Ryzodeg 1001U/ml Penfill 3 ml is a combination of two drugs, namely, Insulin Aspart and Insulin
Degludec. Insulin aspart is a fast-acting or short-acting form of insulin that helps lower blood sugar
levels after food intake. Insulin degludec is a long-acting form of insulin which begins working after 60
minutes and is a long-acting insulin preparation (lasts for more than 24 hours). Ryzodeg 1001U/ml
Penfill 3 ml stimulates the recovery of sugar in muscle and fat cells and suppresses sugar production in the liver. Together, Ryzodeg 1001U/ml penfill 3 ml confirm rapid and stable sugar control by helping
reuptake of sugar in fat cells and muscle, and suppressing the creation of sugar in the liver.

Take Ryzodeg 10011J/ml Penfill 3 ml as prescribed by your doctor. You are advised to take Ryzodeg
1001U/ml penfill 3 ml for as long as your doctor has prescribed it for you depending on your medical
conditions. You may experience rash, injection site allergic reaction, weight gain, oedema (tissue
swelling or fluid overload), lipodystrophy (skin thickening or pits at the injection site), hypoglycemia
(low blood glucose level), itching. Most of these side effects of Ryzodeg 1001U/ml Penfill 3 ml do not
require medical attention and gradually resolve over time. However, if the side effects are persistent,
reach out to your doctor.